• OurPharma LLC

Addressing Drug Shortages

Updated: Feb 12

In Part 6 of their Viewpoint series, titled “Ensuring a resilient US prescription drug supply,” Center for Infectious Disease Research and Policy (CIDRAP) stated:

“Shortages have limited critical drugs for treating COVID-19 patients, including propofol, albuterol, midazolam, hydroxychloroquine, cisatracurium, rocuronium, fentanyl, azithromycin, vancomycin, and others. In fact, 72.5% of them (29 of 40) currently have shortage problems, according to the American Society of Health-System Pharmacists (ASHP).”

As an FDA-registered 503B outsourcing facility, OurPharma is dedicated to addressing the most crucial drug shortages across the United States. To learn more about OurPharma and the steps we’re taking to alleviate shortage concerns with our member hospitals, please visit our website or contact us at